Quantitative Determination of JAK2 V617F by TaqMan: An Absolute Measure of Averaged Copies per Cell That May Be Associated with the Different Types of Myeloproliferative Disorders

This publication has 25 references indexed in Scilit:

• Absence of FTL3 mutations in patients with JAK2^V617F mutation negative essential thrombocythemia
  American Journal of Hematology, 2007
• Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression
  Blood, 2006
• JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility
  The Journal of Molecular Diagnostics, 2006
• Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood
  Pathology, 2006
• Combined Locked Nucleic Acid and Molecular Beacon Technologies for Sensitive Detection of the JAK2V617F Somatic Single-Base Sequence Variant
  Clinical Chemistry, 2006
• Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis
  The Journal of Molecular Diagnostics, 2006
• Identification of the JAK2 V617F Mutation in Chronic Myeloproliferative Disorders Using FRET Probes and Melting Curve Analysis
  American Journal of Clinical Pathology, 2006
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Management of Polycythemia Vera and Essential Thrombocythemia
  Hematology-American Society Hematology Education Program, 2005
• Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms
  Leukemia, 2003